EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

In vivo CRISPR screens identify Mga as an immunotherapy target in triple-negative breast cancer

Xu Feng, Chang Yang, Yuanjian Huang iD, Dan Su, Chao Wang, Lori Lyn Wilson, Ling Yin iD, Mengfan Tang, Siting Li, Zhen Chen, Dandan Zhu, Shimin Wang und 10 weitere

Proceedings of the National Academy of Sciences · 2024

DOI: 10.1073/pnas.2406325121 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, 2024. Verfasst von Xu Feng und 21 weiteren Autor:innen. Beteiligte Einrichtung: Pancreas Center, The First Affiliated Hospital of Nanjing Medical University, Nanjing 210000, China. Hauptthemen laut MEDLINE: Immunotherapy, Triple Negative Breast Neoplasms, Tumor Microenvironment. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NCI NIH HHS, HHS | NIH | National Cancer Institute (NCI), HHS | National Institutes of Health (NIH).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Immune evasion is not only critical for tumor initiation and progression, but also determines the efficacy of immunotherapies. Through iterative in vivo CRISPR screens with seven syngeneic tumor models, we identified core and context-dependent immune evasion pathways across cancer types. This valuable high-confidence dataset is available for the further understanding of tumor intrinsic immunomodulators, which may lead to the discovery of effective anticancer therapeutic targets. With a focus on triple-negative breast cancer (TNBC), we found that Mga knock-out significantly enhances antitumor immunity and inhibits tumor growth. Transcriptomics and single-cell RNA sequencing analyses revealed that Mga influences various immune-related pathways in the tumor microenvironment. Our findings suggest that Mga may play a role in modulating the tumor immune landscape, though the precise mechanisms require further investigation. Interestingly, we observed that low MGA expression in breast cancer patients correlates with a favorable prognosis, particularly in those with active interferon-γ signaling. These observations provide insights into tumor immune escape mechanisms and suggest that further exploration of MGA’s function could potentially lead to effective therapeutic strategies in TNBC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ImmunotherapyTriple Negative Breast NeoplasmsTumor MicroenvironmentAnimalsFemaleHumansMiceCell Line, TumorClustered Regularly Interspaced Short Palindromic RepeatsCRISPR-Cas SystemsGene Expression Regulation, NeoplasticInterferon-gammaTumor EscapeBasic Helix-Loop-Helix Proteins

Stichwörter der Autor:innen

CRISPR screenMGAbreast cancerimmune evasionin vivo screen

Substanzen

Interferon-gammaMGA protein, humanBasic Helix-Loop-Helix Proteins

Autor:innen und Institutionen

  • Pancreas Center, The First Affiliated Hospital of Nanjing Medical University, Nanjing 210000, China.
  • Pancreas Institute, Nanjing Medical University, Nanjing 210000, China.
  • Department of General Surgery, The First Affiliated Hospital of Nanjing Medical University, Nanjing 210000, China.
  • Department of Experimental Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030.
  • Department of Gynecology Oncology, Harbin Medical University Cancer Hospital, Harbin 150086, China.
  • Department of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030.

ORCID-Profile: Yuanjian Huang, Ling Yin, Litong Nie, Jae-Il Park, Traver Hart, Dadi Jiang, Junjie Chen

Förderung

  • NCI NIH HHS
  • HHS | NIH | National Cancer Institute (NCI)
  • HHS | National Institutes of Health (NIH)
  • NIH HHS
  • NIGMS NIH HHS
  • Cancer Prevention and Research Institute of Texas (CPRIT)
  • NEI NIH HHS
  • NCRR NIH HHS

Zitieren

APA

Feng, X., Yang, C., Huang, Y., Su, D., Wang, C., Wilson, L. L., Yin, L., Tang, M., Li, S., Chen, Z., Zhu, D., Wang, S., Zhang, S., Zhang, J., Zhang, H., Nie, L., Huang, M., Park, J. I., Hart, T., …, & Chen, J. (2024). In vivo CRISPR screens identify Mga as an immunotherapy target in triple-negative breast cancer. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.2406325121

Vancouver

Feng X, Yang C, Huang Y, Su D, Wang C, Wilson LL, et al. In vivo CRISPR screens identify Mga as an immunotherapy target in triple-negative breast cancer. Proceedings of the National Academy of Sciences. 2024. doi:10.1073/pnas.2406325121

BibTeX
@article{Feng2024,
  author = {Feng, Xu and Yang, Chang and Huang, Yuanjian and Su, Dan and Wang, Chao and Wilson, Lori Lyn and Yin, Ling and Tang, Mengfan and Li, Siting and Chen, Zhen and Zhu, Dandan and Wang, Shimin and Zhang, Shengzhe and Zhang, Jie and Zhang, Huimin and Nie, Litong and Huang, Min and Park, Jae-Il and Hart, Traver and Jiang, Dadi and Jiang, Kuirong and Chen, Junjie},
  title = {In vivo CRISPR screens identify Mga as an immunotherapy target in triple-negative breast cancer},
  journal = {Proceedings of the National Academy of Sciences},
  year = {2024},
  doi = {10.1073/pnas.2406325121}
}
Kostenlos starten →